-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On United Therapeutics with Overweight Rating, Announces Price Target of $405

Benzinga·06/02/2025 13:57:50
Listen to the news
Cantor Fitzgerald analyst Olivia Brayer initiates coverage on United Therapeutics (NASDAQ:UTHR) with a Overweight rating and announces Price Target of $405.